These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 3279318)

  • 1. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.
    Madsen JC; Superina RA; Wood KJ; Morris PJ
    Nature; 1988 Mar; 332(6160):161-4. PubMed ID: 3279318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunological unresponsiveness using recipient cells transfected with donor class I or class II MHC genes.
    Madsen JC; Wood KJ; Superina RA; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):477. PubMed ID: 2495614
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo.
    Bell Y; Shoskes D; Morris P; Wood K
    Transplant Proc; 1993 Feb; 25(1 Pt 1):359. PubMed ID: 8438334
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
    Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
    Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral transfer of a single donor-specific MHC class I gene to recipient bone marrow cells can induce specific immunological unresponsiveness in vivo.
    Fry JW; Morris PJ; Wood KJ
    Gene Ther; 2002 Feb; 9(3):220-6. PubMed ID: 11859426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
    Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
    J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex.
    Knechtle SJ; Wang J; Jiao S; Geissler EK; Sumimoto R; Wolff J
    Transplantation; 1994 Apr; 57(7):990-6. PubMed ID: 8165719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness.
    Roelen DL; Dover EL; Niimi M; Young NT; Morris PJ; Wood KJ
    Eur J Immunol; 1996 Jul; 26(7):1468-74. PubMed ID: 8766548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
    Saitovitch D; Morris PJ; Wood KJ
    Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of MHC-deficient mouse heterotopic cardiac allografts.
    Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
    Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. Role of class I and class II major histocompatibility complex.
    Sheng-Tanner XF; Miller RG
    Transplantation; 1994 Apr; 57(7):1081-7. PubMed ID: 8165707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor antigen-presenting cells are important in the development of obliterative airway disease.
    Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.